Topic 4 sbir
Active Definitive Contract Awarded Last action
- Contract number
- 140D0426C0009
- Awardee
-
Halcyon Biomedical Inc. UEI C15ACBHQ4P67
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $600,000
Award facts
- Opportunity
-
- Research and Development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Program Pre-Solicitation · 47QFCA24R0036 · Posted May 21, 2024
- Contract value 100% obligated
- $600,000.00 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Friendswood, TX 77546, USA
- Research
- STTR Phase I
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $600,000 |
About this award
The National Institutes of Health awarded a $600,000 definitive contract to Halcyon Biomedical Inc. for a point-of-care system for cell therapy manufacturing and delivery on March 2, 2026, under a total small business set-aside.
The contract stems from ARPA-H's FY2024 SBIR/STTR topic areas. GSA AAS Innovation issued the pre-solicitation notice on behalf of ARPA-H on May 21, 2024, with proposals due July 2, 2024. The solicitation sought innovative research and development across multiple advanced healthcare technology areas, including cell and gene therapy manufacturing technologies, evaluated on technical merit, innovation, personnel, facilities, and commercial potential. Place of performance is Friendswood, TX. The contract is firm fixed price with an ultimate completion date of September 1, 2027.
Quick answers
Who was awarded contract 140D0426C0009?
140D0426C0009 was awarded to Halcyon Biomedical Inc. by Interior Business Center (Office of Policy Management and Budget) on February 24, 2026.
How much is contract 140D0426C0009 worth?
The government has obligated $600,000 on 140D0426C0009.
Which agency awarded contract 140D0426C0009?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0426C0009, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D0426C0009 competed?
The extent of competition for 140D0426C0009 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award